Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression

NCT00518986 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

249

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Disorders
Obstructive Sleep Apnea
Major Depressive Disorder
Dysthymic Disorder

Interventions

DRUG: armodafinil
DRUG: placebo

Sponsor

Cephalon